Obesity Rx: How to Use New Medications in Cli...

Diabetes and obesity are on the rise, and there are new tools to help the prevention and management of this twin epidemic of "diabesity" in primary care. Drs Robert Kushner and Tim Garvey discuss. Relevant disclosures can be found with the episode show notes on Medscape (https:// ...  Show more

How do you medically evaluate a person who presents with obesity? Drs Robert Kushner and Amanda Velazquez share practical tools and pearls for community clinicians. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/982 ...  Show more

New weight-loss drugs have transformed care for people with obesity. In this Clinical Reviews podcast, Robert F. Kushner, MD, MS, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss prescribing these drugs to im ...

Hone your obesity medicine skills in primary care! We discuss overcoming barriers, patient counseling, obesity pathophysiology, motivational interviewing, tools and tips from a weight loss program, and how to discuss medications for weight loss including phentermine/topiramate, b ...  Show more

Learn how to prescribe affordable, effective medications for obesity medicine! We discuss metformin, naltrexone, bupropion, phentermine, topiramate, GLP1 agonists, and how to counsel patients about the available weight loss modalities. Dr. Fatima Cody Stanford (@AskDrFatima) of M ...  Show more

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights ar ...  Show more